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Various proteins adsorb spontaneously on the sidewalls of acid-oxidized single-walled 
carbon nanotubes.  This simple non-specific binding scheme can be used to afford non-
covalent protein-nanotube conjugates.  The proteins are found to be readily transported 
inside various mammalian cells with nanotubes acting as the transporter via the 
endocytosis pathway.  Once released from the endosomes, the internalized protein-
nanotube conjugates can enter into the cytoplasm of cells and perform biological 
functions, evidenced by apoptosis induction by transported cytochrome c.  Carbon 
nanotubes represent a new class of molecular transporters potentially useful for future in-
vitro and in-vivo protein delivery applications. 
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Introduction 
The interaction between nanostructured materials and living systems is of 
fundamental and practical interest and will determine the biocompatibility, potential 
utilities and applications of novel nanomaterials in biological settings.  The pursuit of 
new types of molecular transporters is an active area of research, due to the high 
impermeability of cell membrane to foreign substances and the need for intercellular 
delivery of molecules via cell-penetrating transporter for drug, gene or protein 
therapeutics.1-3  Recently, we and others4-8 have uncovered the ability of single-walled 
carbon nanotubes (SWNTs) to penetrate mammalian cells and further transport various 
cargos inside cells including small peptides,5 the protein streptavidin4 and nucleic 
acids.6,8  In our work of nanotube internalization and streptavidin transporting using 
nanotube carriers4 and the work of Cherukiri et al.7 on nanotube uptake, the 
internalization mechanism was attributed to endocytosis.  In the work of Pantarotto et 
al.5, Bianco et al.8 and Lu et al.,6 nanotube uptake was suggested to be via insertion and 
diffusion through the lipid bilayer of cell membrane.  While the uptake mechanism awaits 
a consensus, it has been consistently reported that well-processed water-soluble 
nanotubes exhibit no apparent cytotoxicity to all living cell lines investigated thus far, at 
least in a time frame of days. 
Here, we report a finding that SWNTs are generic intracellular transporters for 
various types of proteins (≤ 80 kD) non-covalently and non-specifically bound (NSB) to 
nanotube sidewalls.  The proteins investigated include streptavidin (SA), protein A 
(SpA), bovine serum albumin (BSA) and cytochrome c (cyt-c).  The intracellular protein 
transporting and uptake via nanotube carriers are also generic for various adherent and 
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non-adherent mammalian cell lines including HeLa, NIH-3T3 fibroblast, HL60 and 
Jurkats cells.  Energy dependent endocytosis is confirmed to be the internalization 
mechanism.  Further, with cytochrome c as the cargo protein, we present an exploration 
of the fate of internalized protein-SWNT-protein conjugates, attempts of releasing the 
conjugates from the endosome vesicles into the cell cytoplasm using chloroquine, and 
investigation of the biological functions of the released proteins. We observe apoptosis or 
programmed cell death induced by cyt-c transported inside cells by SWNTs after release 
from the endosomes.  The results provide the first proof of concept of in vitro biological 
functionality and activity of proteins delivered by SWNT molecular transporters.   
 
Materials and Methods 
Materials.  Alexa-fluor 488-labeled  streptavidin (SA, molecular weight 60 kD), 
alexa-fluor bovine serum albumin (BSA, 66 kD) were purchased from Molecular Probes 
Inc.  Protein A (42 kD), cytochrome c (12 kD) and Fluorescein isothiocyanate-labeled 
human immunoglobin G (hIgG, 150 kD) were obtained from Aldrich.   
Fluorescent labeling of proteins.  Cyt-c and SpA were fluorescently labeled with 
Alexa-fluor 488 moieties by a protein labeling kit obtained from Molecular Probes Inc.  
In brief, a protein solution at a concentration of 2 mg/mL in standard phosphate buffer 
saline was mixed with 50 µL of sodium bicarbonate solution and the provided vial of 
Alexa- fluor dye and reacted for 1 h at room temperature.  After reaction, the protein-dye 
conjugate was flowed through a gel separation column (Bio-rad Biogel P-30) for 
purification.  The resulting fluorescently labeled protein solution was then diluted to a 
concentration of ~ 10 µM in PBS. 
 4
Purification, cutting and oxidation of SWNTs.   Similar to the steps described 
previously,4,9,10 SWNTs (20 mg) grown by laser ablation were mixed with 100 mL of 2.5 
M HNO3, refluxed for about 36 h, sonicated with a cup-horn sonicator (Branson Sonifer 
450) for 30 min to cut the nanotubes into short segments and refluxed again for another 
36 h.  After this treatment, the mixture was filtered through a polycarbonate filter 
(Whatman, pore size 100 nm), rinsed thoroughly and then re-suspended in pure water by 
sonication.  The aqueous suspension was then centrifuged at 7000 rpm (revolutions per 
minute) for about 5 min to remove any large impurities from the solution.  SWNTs after 
these processing steps were in the form of short (tens to hundreds nanometers) individual 
tubes (~1.5 nm in diameter) or small bundles (up to 5 nm in diameter) and re-suspended 
to give a concentration of ~0.04-0.05mg/mL. Acidic oxygen groups (e.g., -COOH) on the 
sidewalls of the tubes rendered solubility or high suspension stability of the SWNTs in 
water and buffer solutions. 
Conjugation of proteins to SWNTs.  A suspension of the oxidized and cut 
SWNTs at a concentration of ~ 0.05 mg/mL was mixed with fluorescently labeled 
proteins (typical protein concentration ~1µM) for ~ 2 h at room temperature prior to 
characterization (by e.g., atomic force microscopy (AFM) for imaging protein-SWNT 
conjugates) or cellular incubation for uptake. After this simple mixing step, proteins were 
found to adsorb non-specifically onto nanotube sidewalls.   
AFM characterization of protein-SWNT conjugates.  AFM was used to study 
non-specific binding of proteins on nanotubes. After SWNT-protein conjugation, a drop 
of the solution (~50 µL) was pipetted onto a clean SiO2 substrate and allowed to stand for 
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~ 30-45 min.  The substrate was then rinsed with copious amount of HPLC grade H2O 
and dried by a N2 stream. 
Incubation of living cells in solutions of protein-SWNT conjugates.  Non-
adherent HL60 and Jurkat cells were both grown in RPMI-1640 cell culture medium 
(Invitrogen) supplemented with 10% fetal bovine serum (FBS).  Adherent HeLa and 
NIH-3T3 cells were grown in DMEM cell medium (Invitrogen) supplemented with 10% 
FBS and 1% penicillin-streptomycin.  The cell density for all cell lines used in the 
incubation was ~ 3x106 cells/mL.   
For incubating HL60 and jurkat cells in nanotube solutions, 100 µL of the cell 
suspension was typically mixed with 100 µL of a protein-SWNT conjugate solution at 37 
°C for 2-3 h in 5% CO2 atmosphere.  The concentration of SWNTs in the incubation 
solution was typically ~0.05 mg/mL.  After incubation, the cells were washed, collected 
by centrifugation and re-suspended in the cell culture medium twice. 
For incubating HeLa and NIH-3T3 cells in nanotube solutions, the cells were 
seeded into 8-well chambered cover slides ~24 h prior to incubation in a protein-SWNT 
solution in DMEM cell growth medium.  The incubation conditions were the same as the 
one for non-adherent cells above.  Since the cells were adhered to the cover-slide surface, 
no centrifugation was needed to separate the cells from the incubation solution. The cells 
were washed by changing the cell medium and then characterized by confocal 
microscopy imaging. 
Confocal microscopy imaging of cells after incubation in solutions of 
fluorescently labeled protein-SWNT conjugates.  All confocal images of cells were 
recorded with a Zeiss LSM 510 confocal microscope immediately (except for cell 
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viability assay described later) following the incubation in solutions of protein-SWNT 
conjugates and washing steps.  In the case of non-adherent cells, 20 µL of the cell 
suspension were pipetted onto a glass cover slide before imaging.  Adherent cells were 
imaged directly in chambered cover slides.   
Flow Cytometry.  The cells were analyzed by a Becton-Dickinson FACScan 
instrument after incubation for 2-3 h in a solution of fluorescently labeled protein-SWNT 
conjugate.  The cell suspension was supplemented with 2% propidium iodide (PI, Fluka 
chemicals) to stain dead cells.  The data presented here represent the mean fluorescence 
obtained from a population of 10,000 cells.  Note that the mean fluorescence reported 
was a measure of fluorescence of live cells only as cells showing high levels of PI 
staining were excluded from the analysis. 
Cell proliferation MTS Assay.  After incubation with the SWNT-streptavidin 
conjugate (unlabeled), HL-60 cells were washed and resuspended in RPMI media.  The 
cells were plated in a 6-well plate at a density of ~ 8 x 103 cells/well.  At 24 h interval, 
Celltiter96 reagent (Promega) was added to one of the wells and allowed to incubate for 
~ 2-3 h at 37 ºC and 5% CO2.  The CellTiter 96 assay uses the tetrazolium compound (3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt; MTS) and the electron coupling reagent, phenazine methosulfate 
(PMS). MTS is chemically reduced by cells into formazan, which is soluble in tissue 
culture medium. The measurement of the absorbance of the formazan can be carried out 
at 490nm. The assay measures dehydrogenase enzyme activity found in metabolically 
active cells. 
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Apoptosis Assay. We use Annexin V labeled with fluorescein isothiocyanate 
(Molecular Probes) as an early stage apoptosis marker. One of the earliest indications of 
apoptosis is the translocation of the membrane phospholipid phosphatidylserine (PS) 
from the inner to the outer leaflet of the plasma membrane. Once exposed to the 
extracellular environment, binding sites on PS become available for Annexin V, a ~35 
kDa Ca 2+-dependent, phospholipid binding protein with a high affinity for PS11 (also see 
Sigma Technical Bulletin number MB-390).  In this study, NIH 3T3 cells were plated and 
incubated with SWNT-cytochrome c as described above.  After incubation, the cells were 
washed, trypsinized to detach them from the plate surface and washed with phosphate 
buffer saline.  Annexin V-FITC was added to the cell suspension in the presence of the 
binding buffer and allowed to react for 20 min at room temperature.  The cells were co-
stained with propidium iodide and immediately analyzed by flow cell cytometry.  
Apoptosis data in Fig. 6 were for cells free of PI-staining recorded ~ 4-5 h after exposure 
to chloroquine with or without (for control) cyt c-SWNT conjugates.  
 
Results and Discussion 
 Protein binding on oxidized SWNTs. The combined treatment of refluxing and 
sonication in nitric acid is known to produce short (50-500nm, Fig. 1a) individual or 
small bundles of SWNTs with oxygen containing groups (e.g., -COOH) along the 
sidewalls and ends of the tubes.4,9,10  These functional groups impart hydrophilicity to the 
nanotubes and make them stable in aqueous solutions (in pure water and various buffers 
including PBS and cell culture media) without apparent aggregation in the timescale 
monitored (1-3 h). In the current work, we found that simple mixing of the oxidized 
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SWNTs with protein solutions led to non-specific binding of proteins to the nanotubes as 
can be gleaned from the AFM data in Fig. 1b-d for BSA, SpA and cyt-c.  AFM imaging 
revealed that the average spacing between proteins adsorbed on SWNTs ranged 
approximately from  ~20-100 nm and the loading appeared to be the highest for cyt-c 
(Fig. 1d) likely due to attractive electrostatic interactions (isoelectric point pI ~ 9.2 for 
cyt-c and the oxidized SWNTs were negatively charged). Proteins with pI < 7 such as SA 
and BSA also exhibited affinity for oxidized SWNT sidewalls (Fig.1b, 1c). We attributed 
the binding to either electrostatic forces between functional groups on SWNTs and 
positively charged domains on proteins, and/or hydrophobic interactions since the SWNT 
sidewalls were not fully oxidized (~tens of nanometer between oxygen groups) and 
contained hydrophobic regions.  
 
We and others previously observed a general phenomenon of protein non-specific 
binding on as-grown and acid-oxidized SWNTs mainly due to hydrophobic 
interactions.12-15  In agreement with Green et al.,14 we found that imparting hydrophilicity 
to SWNTs by oxidation was insufficient to block protein NSB.  This result was utilized 
a b  c d 
Figure 1.  AFM images of various SWNT samples deposited on SiO2 substrate.  
(a) Oxidized SWNT prior to conjugation with proteins and after conjugation to 1 µM 
of (b) Alexa-Fluor 488 BSA, (c) Alexa-Fluor 488 spA and (d) Alexa-Fluor 488 
cytochrome C.  Scale bar = 100 nm.
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from here on to create non-covalent protein-SWNT conjugates for cellular uptake.  Note 
that in our earlier protein/SWNT intracellular transport, binding between nanotube 
transporters and SA was obtained through biotin-streptavidin conjugation.4 
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Figure 2.  Confocal microscopy and flow cytometry characterization of cells after 
incubation in protein-SWNT (proteins labeled to be green fluorescent) solutions for 2 
h.  (a) HL60 cells after incubation in streptavidin SA-SWNTs (b) HL60 cells after 
incubation in BSA-SWNTs.  (c) HeLa cells after incubation in SA-SWNTs in the 
presence of the FM 4-64, a red membrane and endocytotic vesicle marker.  Yellow 
color in the image is due to co-localization of fluorescently labeled green proteins and 
red FM 4-64.  (d) HeLa cells after incubation in cytochrome c-SWNTs in the presence 
of FM 4-64.  Note that in Fig.2c&2d, the cell nucleus (dark circular or oval-shaped 
regions) appears free of fluorescence with the internalized protein-SWNT conjugates 
accumulating outside of the nucleus region and outlining parts of the nucleus 
boundary. (e) Cell cytometry data for untreated HL60 cells (labeled as ‘control’), and 
HL60 cells incubated in solutions of fluorescently labeled SA and SpA respectively 
(blue bars) and treated with the respective fluorescent protein-SWNT conjugate 
(purple bars). 
c d 
a b 
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Cellular uptake of protein-SWNT conjugates.  To investigate the fate of the SWNT-
protein conjugates in-vitro by standard characterization tools, fluorescently labeled 
proteins by alexa-fluor 488 (excitation wavelength ~488 nm and emission wavelength ~ 
510 nm) were used.  The proteins were conjugated to SWNTs in concentration ranging 
from 100 nM - 1µM with SWNT concentration of ~ 0.05mg/mL.  For various non-
adherent cells (HL-60 and jurkat) and adherent cell lines (HeLa and NIH-3T3), we found 
that intracellular internalization of protein-SWNT conjugates was generic for the various 
proteins investigated by confocal microscopy imaging (Fig. 2a-2d) and flow cytometry 
(Fig. 2e).  Optical confocal microscopy sections (in the Z-direction) of the cells revealed 
that fluorescence was mainly originated within the cell interior, though cell membrane-
surface bound fluorescence of protein-SWNT conjugates was also present. As control 
experiments, we carried out incubations of cells in solutions that contained fluorescently 
labeled proteins alone and compared the detected fluorescence level with cells exposed to 
protein-SWNTs by flow cytometry.  As shown in Fig. 2e, the fluorescence level detected 
for the former was low compared to the latter, suggesting that while proteins in solutions 
were unable to traverse across cell membranes by themselves, SWNTs were effective in 
transporting protein cargos inside cells. 
 The observed internalization of the non-covalently bound proteins via oxidized 
SWNT transporters was similar to that of streptavidin transported by biotinylated SWNTs 
for which endocytosis was identified as the internalization pathway.4  Endocytosis is a 
well known mechanism for a wide range of species traversing cell membranes including 
large liposomes and nanoparticles, and is an energy-dependent internalization mechanism 
hindered at low temperatures.16-18  Indeed, by incubating cells in protein-SWNT 
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conjugates at 4 ºC, we observed no uptake of the conjugates (Fig. 3), suggesting the 
endocytosis mechanism for the cellular uptake of protein-nanotube conjugates in 
experiments performed at 37 ºC.   
 
We are currently investigating details of the endocytotic uptake of SWNT 
conjugates to address whether the conventional endocytosis mechanism involving 
clathrin coated pits19 on cellular membranes are involved for the nanotube uptake. We 
speculate that SWNTs exhibit high binding affinity to certain cell membrane species that 
facilitate the high efficiency of nanotube binding and subsequent internalization.  This 
binding affinity exists even after protein adsorption on SWNTs since the protein coverage 
is often incomplete4 and the nanotube/protein complex still exhibit substantial 
hydrophobicity. The uptake mechanism certainly warrants much future effort and we will 
present our detailed mechanistic study in a separate publication.  Discrepancy in uptake 
mechanisms for nanotubes, i.e., endocytosis found by us and phagocytosis proposed by 
Cherukiri et. al.,7 versus insertion and diffusion by Pantarotto et al. and Bianco et al.5,8 
needs to be reconciled. 
Figure 3.  Experiments at various temperatures.  Confocal images of HL60 cells after 
incubation in cytochrome c-SWNTs for 2 hrs at (a) 37 °C and (b) 4 °C respectively 
a b 
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 We note that while binding and intracellular protein transporting by SWNTs 
appeared general for small to medium sized proteins (molecular weight <= 80 kD), 
cellular uptake of protein-SWNT conjugates was poor and nearly non-existent for a large 
protein investigated, i.e., human immunoglobulin (molecular weight ~150kD).  This 
observation (data not shown) is not understood currently and is likely related to the large 
size of the antibody cargo, which may have caused inefficient loading of hIgG on 
SWNTs due to the large size mismatch (~7-8nm for hIgG; ~1.5 nm in diameter for 
SWNT) or inefficient endocytosis due to the large conjugates.  The issue of binding and 
transporting of large proteins and antibodies with SWNTs is open for further 
investigation. 
Cell proliferation after nanotube uptake by MTS assay. Biocompatibility is a 
major concern when introducing any foreign substances inside living systems. Thus far, 
several groups have reported that relatively pure, well solubilized short carbon nanotubes 
appear nontoxic once internalized into mammalian cells without apparent adverse effects 
to cell viability.4-8  In the current work, we further assessed the biocompatibility of 
carbon nanotubes by monitoring cell proliferation.  We used the CellTiter 96 MTS assay 
(Promega) to examine the proliferation of HL60 cells following exposure to SWNT-
protein conjugates.  The CellTiter 96 assay uses the tetrazolium compound (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, 
inner salt; MTS) and the electron coupling reagent, phenazine methosulfate (PMS). MTS 
is chemically reduced by cells into formazan, which is soluble in tissue culture medium. 
The absorbance of the formazan salt can be measured at 490 nm and correlates to the 
number of cells in the suspension.  The absorbance from the cells incubated with the 
 13
SWNT-protein conjugates was measured over a period of 5 days in parallel with control 
cells never exposed to any nanotubes.  As shown in Fig. 4, the absorbance detected by a 
UV-VIS spectrophotometer was very similar for cells with and without exposure to 
SWNTs over the 5 day monitoring period. This result suggest that cell proliferation and 
cell viability was unaffected by the internalized carbon nanotubes.   
 
Figure 4.  Cell Proliferation Assay.  Cells are incubated with SWNT-SA 
conjugate (without fluorescent label) for 2 hrs. After incubation, cells are washed, 
collected and resuspended in cell media. Confocal images of HeLa cells taken (a) 
24hrs and (b) 48hrs after incubation.   The cells are plated at a cell density of 8 x 
103 cells/well and returned to a CO2 incubator at 37 ºC and 5% CO2 .  (c) At 24 hr 
interval after the initial SWNT incubation, CellTiter96 reagent is added to the cell 
suspension, and allowed to incubate for 2 hrs at 37 ºC.  The absorbance is then 
taken at 490 nm.  The proliferation of the cells incubated with SWNT is 
monitored for a period of up to 5 days after initial exposure to SWNT (red) and 
does not show any deviation from the proliferation of untreated cells (blue).   
a b 
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 Endosome release.  As observed previously, SWNT-protein conjugates, once 
internalized inside mammalian cells were colocalized with a red endocytosis endosome 
marker FM 4-64 (Fig. 2c, 2d),4 corresponding to the containment of internalized species 
in endosomal lipid vesicle compartments (specifically labeled by red FM-64). Consistent 
with this was the observed punctuate fluorescence (Fig.2a-b) inside cells due to 
endosomal confinement of the internalized species.  The endocytosis pathway can be 
illustratively described as the engulfment of the cell membrane and formation of a lipid 
vesicle around the species to be internalized.16-18 Once inside the cells, the endosomes 
could fuse with the cell lysosomes, which may lead to later degradation of the 
internalized species in the lysosomes.  To avoid the fate of lysosome degradation, it is 
important to trigger endosomal release of the internalized molecules into the cell 
cytoplasm.  This will then open up the possibility of obtaining biological functionality for 
the internalized cargo molecules.  Note that green fluorescence (proteins) non-
overlapping with FM 4-64 markers were sometimes observed (Fig.2c-d), suggesting 
certain internalized species might have been released from the endosome via an 
intentional mechanism.   
Various approaches have been suggested in the past to actively initiate endosomal 
release of endocytosed species including complexation of the cargo molecules with pH 
sensitive polymers or highly amine-rich moieties.20,21  These methods make use of the pH 
difference across the endosome membrane and the pH response of the polymers or 
amines.  For SWNT transporters, similar complexation schemes can be developed to 
afford nanotube transporters containing an endosome-releasing agent. While such an 
effort warrants detailed investigations separately from the current work, we describe here 
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the release of internalized protein-SWNT conjugates from the endosomal compartments 
by adding chloroquine to cell medium during incubation of cells in protein-SWNT 
conjugates. Chloroquine is a membrane permeable base that has been shown to localize 
inside endosomes and cause an increase in pH.22 The resulting osmotic pressure can lead 
to swelling of the endosomal compartments and eventual rupture.23 In experiments 
carried out with and without chloroquine, we noticed a difference in the distribution of 
the detected fluorescence inside the cells.  In the absence of chloroquine, discrete 
punctate fluorescence spots were observed within the cells (Fig. 5a), similar to those in 
Fig. 2 and 3.  In contrast, when cells were simultaneously exposed to protein-SWNT 
conjugates and 100 µM chloroquine, fluorescence signals inside the cells appeared to be 
diffuse and uniform (Fig. 5b), due to redistributed conjugates over the entire cell 
cytoplasm after endosome releasing. 
 
Towards biological functionality: apoptosis induction by SWNT transported 
cytochrome c.  Building upon the results above on binding and intracellular transporting 
of proteins with SWNT carriers and cargo releasing into cell cytoplasm, we carried out an 
Figure 5.  Endosomal Rupture.  (a) Cells are incubated with (a) SWNT-CytC conjugate 
and (b) SWNT-CytC + 100 µM of chloroquine at 37 ºC and 5% CO2 .  Confocal images are 
taken immediately after incubation and washing.  Confocal images indicating the release of 
the SWNT-protein conjugate from the endosome, overall green color across the cell in (b) 
vs. green individualized spots inside the cells in (a). 
a b 
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investigation of biological functions of the transported proteins. We chose cyt-c for this 
exploration due to the high degree of loading of cyc-c on SWNTs (Fig.1d)  and high 
efficiency of endocytosis of the cyt-c/SWNT conjugates (Fig.5a). Cyt-c is the smallest 
protein in the current work with a molecular weight of 12 kD and has the highest pI of 
~9.2 to afford a high degree of binding onto the negatively charged oxidized SWNTs. It 
has been suggested that cells during apoptosis or programmed cell death may release 
cytochrome c from mitochondria.24,25 When microinjected, cytochrome c has been shown 
to induce or activate apoptosis by bypassing the need for release of cytochrome c from 
mitochondria.24  Through interaction with apoptotic protease activating factors (Apaf), 
cyt-c in the cytosol is believed to initiate the activation cascade of caspases that leads to 
cell death.25   
HeLa and NIH-3T3 cell lines, shown previously to undergo cyt-c-induced 
apoptosis were investigated in this study for intracellular transporting of cyt-c with 
SWNTs and for apoptosis assay.25 Unlike the proteins used for other uptake experiments, 
cyt-c used for binding to SWNTs and transported inside cells for apoptosis assay were 
free of any fluorescence label. After incubation of cells in the cyt-c-SWNT conjugates, 
apoptosis was analyzed using fluorescently (FITC) labeled Annexin V. Annexin V-FITC 
is an efficient marker for early stage apoptosis as it binds specifically to the exposed 
phospholipd phosphatidylserine (PS) translocated from the inner to the outer leaflet of the 
plasma membrane during apoptosis. Once exposed to the extracellular environment, 
binding sites on PS become available for Annexin V, a ~35 kDa Ca 2+-dependent, 
phospholipid binding protein with a high affinity for PS.11  
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For NIH-3T3 cells incubated with cyt-c alone and cyt-c-SWNT conjugates, we 
analyzed the degree of Annexin V staining by both confocal microscopy (Fig. 6a,6b) and 
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Figure 6.  Apoptosis induction by cytochrome c cargos transported inside cells by 
SWNTs.  (a) Confocal image of NIH-3T3 cells after 3 h incubation in 50 µM of 
cytochrome c alone (no SWNT present) and 20 min staining by Annexin V- FITC 
(green fluorescent).  (b) Images of cells after incubation in 50 µM cytochrome c-
SWNTs in the presence of 100 µM chloroquine and after Annexin V- FITC staining.  
(c) Cell cytometry data of the percentages of cells undergoing early stage apoptosis (as 
stained by Annexin V-FITC) after exposure to 100 µM of chloroquine only (labeled 
‘untreated’), SWNT +100 µM of chloroquine, 10 µM of cyt-c + 100 µM chloroquine, 
10 µM of cyt-c-SWNT + 100 µM chloroquine  and cyt c-SWNT without chloroquine. 
The inset shows a representative confocal image of the blebbing of the cellular 
membrane (stained by Annexin V-FITC) as the cell undergoes apoptosis. Note that PI 
co-staining was used and all data shown here excluded PI-positive cells and are 
recorded ~ 4-5 h after exposure to chloroquine.  The level of PI staining for all cells 
here was a normal ~ 4-6% out of ~10,000.  
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cell flow cytometry (Fig. 6c). We observed significantly higher percentages of apoptosed 
cells incubated with cyt-c-SWNT conjugates than those incubated with cyt-c alone (Fig. 
6a vs. 6b; also see Fig.6c). We also encountered apoptotic cells exhibiting blebbing of the 
cellular membrane stained by Annexin V-FITC (Fig.6c inset), a known phenomenon for 
cells undergoing apoptosis. 
To investigate the effect of endosomal release on the efficiency of apoptosis 
induction by cyt-c transported by SWNTs, we carried out incubations of cells in cyt-c-
SWNT with and without the presence of chloroquine. Higher degrees of apoptosis were 
consistently observed for cells treated with cyt-c-SWNT in the presence of chloroquine 
(Fig.6c) as attributed to the more efficient endosomal releasing of proteins. Note that the 
apoptosis results presented here were reproduced at least three times in independent 
experimental runs. Also, unless otherwise stated, chloroquine was used in all incubations 
including control experiments for fair comparisons with the positive control (cyt-c-
SWNT + chloroquine incubation).  Taken together, our data suggested that the 
cytochrome c bound and transported inside cells by SWNT carriers remained biologically 
active for apoptosis induction.  It was unclear however, whether the cytochrome c 
functionality was obtained after detaching from the SWNT sidewalls or with the proteins 
bound to nanotubes.  Future work is required to elucidate this issue.  
 
Conclusion 
We have found that various proteins adsorb spontaneously on the sidewalls of 
acid-oxidized SWNTs and this non-specific binding afford non-covalent protein-
nanotube conjugates.  Nanotubes appear to be generic intracellular protein transporters 
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for various proteins and mammalian cell lines. Cellular uptake is via the energy 
dependent endocytosis pathway and the endocysed species are confined inside 
endosomes lipid compartments. Once released into the cytoplasm of cells, the proteins 
can perform biological functions as evidenced by apoptosis induction by the transported 
cytochrome c. The door is currently open for addressing outstanding issues and capturing 
opportunities presented by nanotube molecular transporters.  The detailed uptake 
mechanisms should be established without ambiguity. Efficient cargo releasing strategies 
should be developed for nanotubes since the use of chloroquine here is only to illustrate 
the need of endosomal release and does not represent a practical approach to for real 
applications. Long term cytotoxicity effects should be established for nanotubes in vitro 
and in vivo. The uniqueness of SWNTs as molecular transporters is beginning to emerge 
and need to be fully developed.  Carbon nanotubes could become a new class of 
molecular transporters for various in-vitro and in-vivo delivery applications. 
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